|9 Months Ended|
Sep. 30, 2022
Note 6. Leases
The Company leases its laboratory, research and administrative office space under various operating leases. In January 2022, the Company recorded a $1.2 million ROU asset and related liability upon the signing of a new 5-year lease in San Diego, California.
The components of operating and finance lease expenses for the three and nine months ended September 30, 2022 and 2021 are as follows:
Components of Lease Expense and Supplemental Information
Amounts reported in the condensed consolidated balance sheets as of September 30, 2022 and December 31, 2021 are as follows:
Schedule of Amounts Reported in the Consolidated Balance Sheet
Other information related to leases from continuing operations for the nine months ended September 30, are as follows:
Schedule of Other Information Related to Lease
Annual payments of lease liabilities under noncancelable leases from continuing operations as of September 30, 2022 are as follows:
Schedule of Annual Payments of Lease Liabilities Under Noncancelable Leases
No definition available.
The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.
Reference 1: http://www.xbrl.org/2003/role/disclosureRef